$0.140
-0.003 (-2.09%)At close
- High
- 0.144
- Open
- 0.139
- VWAP
- 0.14
- Volume
- 41.38K
- Mkt Cap
- —
- Low
- 0.131
- Amount
- 5.73K
- EV/EBITDA, TTM
- 0.00
Knorex Ltd. is a Business to Business (B2B) technology company. The Company is specialized in providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its flagship product, Knorex XPO, is a self-service enterprise-grade cloud platform with a comprehensive suite of advertising management and execution (AMX) applications.
AI analysis of Knorex Ltd (KNRX)
SellKNRX is not a good buy right now due to its significant financial struggles and compliance issues. The current price is $0.14, which is near its 52-week low of $0.13, and the stock has experienced a staggering year-to-date change of -89.98%. Additionally, the RSI is at 31.51, indicating that the stock is oversold but lacks positive momentum for recovery. The company has failed to file its annual report on time, which poses a risk of delisting, further undermining investor confidence.
Valuation Metrics
Events Timeline
News
8.509-01NewsfilterKNOREX Launches KAI Assist to Enhance Ad Management
- 9.508-21Newsfilter
KNOREX Releases 2025 Financial Statements with Going Concern Emphasis
- 8.508-19Newsfilter
KNOREX Successfully Lists on NYSE American, Driving AI Growth
7.005-22seekingalphaKNOREX Fails to File Annual Report on Time
- 8.504-29Newsfilter
KNOREX Launches AI Advertising Optimization Tools
KNRX FAQ — answered by Alphio AI
Knorex Ltd. is a Business to Business (B2B) technology company. The Company is specialized in providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its flagship product, Knorex XPO, is a self-service enterprise-grade cloud platform with a comprehensive suite of advertising management and execution (AMX) applications. It operates in the Technology sector.
KNRX is not a good buy right now due to its significant financial struggles and compliance issues. The current price is $0.14, which is near its 52-week low of $0.13, and the stock has experienced a staggering year-to-date change of -89.98%. Additionally, the RSI is at 31.51, indicating that the stock is oversold but lacks positive momentum for recovery. The company has failed to file its annual report on time, which poses a risk of delisting, further undermining investor confidence.
Community
More ↗No posts yet
Sign up or log in to join the discussionRelated articles
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.